InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,044.00
(
1.16%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.00
(
-2.24%
)
Bitcoin
59,121.58
(
-0.46%
)
Post# of 81470
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

million

Send PM Follow Ignore
Followers 186
Posts 35715
Boards Moderated 0
Alias Born 12/27/2004

million

Re: dart1961 post# 38312

Monday, 01/12/2009 11:51:24 AM

Monday, January 12, 2009 11:51:24 AM

Post# of 81470
Still waiting for NRGN to announce further developments from their last news:

Neurogen Corporation (Nasdaq: NRGN), a drug development company focused on improved drugs for psychiatric and neurological disorders, today announced it has entered into a definitive agreement to sell its C5a patent estate and related assets to a major pharmaceutical company for $2.25 million. Also, on December 16th, 2008, Neurogen received the final payment on the previously announced $3 million sale of its chemical library to a major pharmaceutical company.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up